All stock lists
Exagen Inc. (NASDAQ:XGN)
US · Delayed Price · Currency is USD
Healthcare · Medical - Diagnostics & Research
7.27-0.21 (-2.81%)
Insider Score
––Not scored
XGN Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
XGN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 19.94 M | 17.31 M | 16.63 M | 17.24 M | 17.20 M | 15.50 M |
| Revenue Growth (YoY) | 15.92 % | 11.67 % | 21.79 % | 37.87 % | 14.19 % | 7.51 % |
| Cost of Revenue | 7.72 M | 7.10 M | 7.42 M | 7.17 M | 6.81 M | 6.38 M |
| Gross Profit | 12.22 M | 10.21 M | 9.21 M | 10.07 M | 10.39 M | 9.12 M |
| SG&A Expense | 12.51 M | 12.07 M | 12.42 M | 11.45 M | 11.54 M | 11.20 M |
| R&D Expense | 1.43 M | 1.55 M | 1.76 M | 1.73 M | 1.48 M | 1.28 M |
| Operating Expenses | 13.94 M | 13.62 M | 14.18 M | 13.18 M | 13.03 M | 12.49 M |
| Operating Income | -1.72 M | -3.41 M | -4.97 M | -3.10 M | -2.63 M | -3.37 M |
| Pretax Income | -3.20 M | -3.93 M | -4.66 M | -7.09 M | -4.40 M | -3.75 M |
| Tax Provision | 0.00 | 36.00 K | 13.00 K | 1.00 K | 37.00 K | 0.00 |
| Net Income | -3.20 M | -3.97 M | -4.67 M | -7.09 M | -4.44 M | -3.75 M |
| EPS (Basic) | -0.13 | -0.17 | -0.21 | -0.31 | -0.21 | -0.20 |
| EPS (Diluted) | -0.13 | -0.17 | -0.21 | -0.31 | -0.21 | -0.20 |
| Shares Outstanding | 24.16 M | 23.85 M | 21.56 M | 22.86 M | 21.09 M | 18.56 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.